Abstract | BACKGROUND:
Buprenorphine is an opioid agonist medication that is both safe and effective in the treatment of opioid use disorders and the prevention of opioid overdoses. Despite this, media coverage has highlighted public concerns about the potential safety consequences of buprenorphine misuse and diversion. To address the possible contribution of buprenorphine to overdose mortality, we systematically tested post mortem blood specimens from decedents who had died of an unintentional drug overdoses in 2013. METHODS: We retrospectively tested consecutive drug overdose cases that occurred from June through October 2013. Cases with available blood specimens were tested for buprenorphine and norbuprenorphine using liquid chromatography-tandem mass spectrometry. Toxicology results were linked to death certificates and case files from New York City Vital Statistics and New York City Office of the Chief Medical Examiner. RESULTS: Of the 98 unintentional drug overdose fatalities tested, only 2 (2.0%) tested positive for buprenorphine metabolites. All 98 unintentional fatalities involved multiple substances. CONCLUSIONS:
|
Authors | Denise Paone, Ellenie Tuazon, Marina Stajic, Barbara Sampson, Bennett Allen, Shivani Mantha, Hillary Kunins |
Journal | Drug and alcohol dependence
(Drug Alcohol Depend)
Vol. 155
Pg. 298-301
(Oct 01 2015)
ISSN: 1879-0046 [Electronic] Ireland |
PMID | 26305073
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2015 Elsevier Ireland Ltd. All rights reserved. |
Chemical References |
- Analgesics, Opioid
- Buprenorphine
- norbuprenorphine
|
Topics |
- Analgesics, Opioid
(blood)
- Buprenorphine
(analogs & derivatives, blood)
- Cause of Death
- Drug Overdose
(blood, mortality)
- Humans
- New York City
(epidemiology)
- Retrospective Studies
|